Premium Nahrungsergänzungsmittel | artgerecht

Insulin-Glucose Ratio: Definition and Clinical Relevance

The insulin-glucose ratio is a diagnostic value that reflects the relationship between insulin and glucose levels in the blood, helping to identify insulin resistance or impaired insulin secretion.

Regular tips about health Regular tips about health

Things worth knowing about "Insulin-Glucose Ratio"

The insulin-glucose ratio is a diagnostic value that reflects the relationship between insulin and glucose levels in the blood, helping to identify insulin resistance or impaired insulin secretion.

What Is the Insulin-Glucose Ratio?

The insulin-glucose ratio (also referred to as the insulin-to-glucose ratio) is a laboratory diagnostic marker that expresses the relationship between the concentration of insulin and glucose in the blood. It is calculated by dividing the fasting insulin level by the fasting blood glucose level. This ratio provides insight into how efficiently the body uses insulin to regulate blood sugar.

An elevated insulin-glucose ratio may indicate insulin resistance -- a condition in which the body's cells become less responsive to insulin, prompting the pancreas to produce more insulin to compensate. This state is closely associated with the development of type 2 diabetes, metabolic syndrome, and cardiovascular disease.

Calculation and Reference Values

The insulin-glucose ratio is calculated using the following formula:

Insulin-Glucose Ratio = Fasting insulin (µU/mL) ÷ Fasting glucose (mg/dL)

As a general guideline, a ratio of less than 0.3 is considered within the normal range in many clinical references. Values above this threshold may suggest hyperinsulinemia or insulin resistance, but must always be interpreted in the appropriate clinical context. Reference ranges can vary depending on the laboratory and the unit of measurement used (mg/dL or mmol/L).

Clinical Significance

The insulin-glucose ratio is primarily used in the diagnosis and monitoring of the following conditions:

Insulin resistance: An elevated ratio suggests reduced insulin sensitivity.
Prediabetes and type 2 diabetes: Early detection of impaired glucose tolerance.
Metabolic syndrome: Assessment of metabolic risk in patients with obesity, hypertension, and dyslipidemia.
Polycystic ovary syndrome (PCOS): Insulin resistance is a common feature of this condition.
Suspected insulinoma: An abnormal ratio may be diagnostically relevant when an insulin-producing pancreatic tumor is suspected.

Comparison with the HOMA-IR Index

A closely related and widely used clinical marker is the HOMA-IR index (Homeostasis Model Assessment of Insulin Resistance). This index also uses fasting insulin and fasting glucose values but is calculated using a specific formula that allows for a more refined assessment of insulin sensitivity. Both markers are complementary and are often evaluated together.

Factors Influencing the Ratio

Several factors can affect the insulin-glucose ratio and must be considered when interpreting results:

Fasting status at the time of blood collection (a minimum of 8 to 12 hours of fasting is recommended)
Body weight and body fat distribution (particularly visceral fat)
Physical activity levels
Medications (e.g., corticosteroids, antidiabetic drugs)
Stress hormones and acute illness
Dietary habits (high-carbohydrate diets can increase insulin production)

Diagnostic Classification

The insulin-glucose ratio is not a standalone diagnostic test but rather a supplementary laboratory parameter. A comprehensive evaluation of glucose metabolism typically includes additional tests such as the oral glucose tolerance test (OGTT), HbA1c levels, and a full blood count and lipid profile.

References

Matthews DR et al. - Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419.
World Health Organization (WHO): Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia. WHO Press, Geneva, 2006.
American Diabetes Association: Standards of Medical Care in Diabetes. Diabetes Care. 2024;47(Suppl 1):S1-S321.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.